Multicentre clinical evaluation of vigabatrin (Sabril®) in mild to moderate partial epilepsies

Seizure

Volumn 6, Issue 3, 1997, Pages 225-231

  Arzimanoglou, Alexis A ^a   Dumas, Caroline ^b   Ghirardi, Laurent ^c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Laboratoires Cassenne   (France)

^c Information et Communication Consultants   (France)

Author keywords

Clinical experience; Partial epilepsy; Secondary generalization; Vigabatrin

Indexed keywords

ANTICONVULSIVE AGENT; VIGABATRIN;

ADOLESCENT; ADULT; AGED; ANTICONVULSANT THERAPY; ARTICLE; CHILD; CLINICAL TRIAL; COGNITIVE DEFECT; COMPLEX PARTIAL SEIZURE; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOCAL EPILEPSY; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHOOL CHILD; SLEEP DISORDER; VERTIGO;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CHILD; EPILEPSIES, PARTIAL; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEIZURES; TREATMENT OUTCOME; VIGABATRIN;

EID: 18544411099     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1059-1311(97)80010-6     Document Type: Article

References (27)

1. Lippert B., Metcalf B.W., Jung M.J. and Casera P. 4-Amino-hex-5-enoic acid, a selective catalytic inhibitor of 4-aminobutyric-acid aminotransferase in mammalian brain. European Journal of Biochemistry 1977; 74: 441-445.
2. Ben-Menachem E., Persson L., Schechter P.J.U. et al. Effects of single doses of vigabatrin on CSF concentrations of GABA, homocarnosine, homovanillic acid and 5-hydroxyindoleacetic acid in patients with complex partial epilepsy. Epilepsy Research 1988; 2: 96-101.
3. Gram L., Blatt Lyon B. and Dam M. Gamma-vinyl-GABA: a single- blind trial in patients with epilepsy. Acta Neurologica Scandinavica 1983; 68: 34-39.
4. Schechter P.J., Nanke N.F., Grove J., Huebert N. and Sjoerdsma A. Biochemical and clinical effects of gamma-vinyl-GABA in patients with epilepsy. Neurology 1984; 34: 182-186.
5. Browne T.R., Mattson R.H., Penry J.K. et al. Vigabatrin for complex partial seizures: multicenter single-blind study with long-term follow up Neurology 1987; 37: 184-189.
6. Cocito L., Maffini M., Perfumo P., Roncallo F. and Loeb C. Vigabatrin in complex partial seizures: a long-term study. Epilepsy Research 1989; 3: 160-166.
7. Tartara A., Manni R., Galimberti C.A. et al. Vigabatrin in the treatment of epilepsy: a long-term follow-up study. Journal of Neurology, Neurosurgery and Psychiatry 1989; 52: 467-451.
8. Dam M. Long-term evaluation of vigabatrin (gamma-vinyl-GABA) in epilepsy. Epilepsia 1989; 30(Suppl. 3): S26-S30.
9. Rémy C. and Beaumont D. Efficacy and safety of vigabatrin in the long-term treatment of refractory epilepsy. British Journal of Clinical Pharmacology 1989; 27(Suppl. 1): 125S-129S.
10. Sander J.W.A.S., Trevisol-Bittencourt P.C., Hart Y.M. and Shorvon S.D. Evaluation of vigabatrin as add-on drug in the management of severe epilepsy. Journal of Neurology, Neurosurgery and Psychiatry 1990; 53: 1008-1010.
11. Reynolds E.H., Ring H.A., Farr, I.N., Heller A.J. and Elwes, R.D.C. Open, double-blind and long-term study of vigabatrin in chronic elilepsy. Epilepsia 1991; 32: 530-538.
12. Sivenius J., Ylinen A., Murros K., Mumford J.P. and Riekkinen P.J. Vigabatrin in drug-resistant partial epilepsy: a 5-year follow-up study. Neurology 1991; 27: 717-723.
13. Livingston J.H., Beaumont D., Arzimanoglou A. and Aicardi J. Vigabatrin in the treatment of epilepsy in children. British Journal of Clinical Pharmacology 1989; 27(Suppl. 1): 109S-112S.
14. Dulac O., Chiron C., Luna D. et al. Vigabatrin in childhood epilepsy. Journal of Child Neurology 1991; 6(Suppl. 2): 2S30-2S37.
15. Gram L., Sabers A. and Dulac O. Treatment of pediatric epilepsies with gamma-vinyl GABA (vigabatrin). Epilepsia 1992; 33(Suppl. 5): S26-S29.
16. Chiron C., Dulac O., Beaumont D., Palacios L., Pajot N. and Mumford J. Therapeutic trial of vigabatrin in refractory infantile spasms. Journal of Child Neurology 1991; 6(Suppl. 2): 2S52-2S59.
17. Aicardi J., Sabril IS Investigator and Peer Review Groups, J. P. Mumford, C. Dumas, S. Wood. Vigabatrin as initial therapy for infantile spasms: a European retrospective survey. Epilepsia 1996; 37: 638-642.
18. Reynolds E.H. Gamma-Vinyl GABA (vigabatrin): Clinical experience in adult and adolescent patients with intractable epilepsy. Epilepsia 1992; 33(Suppl. 5): S30-S35.
19. Aicardi J. General principles of management. In: Epilepsy in Children. ICNA series, Raven Press, 1994: pp. 394-428.
20. De Bittencourt P.R.M., Mazer S., Marcourakis T., Bigarella M.M., Ferreira Z.S. and Mumford J.P. Vigabatrin: clinical evidence supporting rational polytherapy in the management of uncontrolled seizures. Epilepsia 1994; 35: 373-380.
21. Kälviäinen R., Mervaala E., Sivenius J. and Riekkinen J. Vigabatrin. Clinical use. In: Antiepileptic druts, 4th edition (Eds R.H. Levy, R.H. Mattson and B.S. Meldrum). New York, Raven Press, 1995: pp. 925-930.
22. Cockerell C., Moriaty J., Trimble M.R., Shorvon S.D. and Sander J.W.A.S. Epidemiological survey of acute psychological disorders in epilepsy. Epilepsia 1995; 36(Suppl. 3): S129 (abstract).
23. Sander J.W.A.S., Hart Y.M., Trimble M.R. and Shorvon S.D. Vigabatrin and psychosis. Journal of Neurology, Neurosurgery and Psychiatry 1991; 54: 435-439.
24. Ring H.A. and Reynolds E.H. Vigabatrin and behaviour disturbance (Letter). Lancet 1990; 335: 970.
25. Snead O.C. III and Hosey L.C. Exacerbation of seizures in children by carbamazepine. New England Journal of Medicine 1985; 313: 916-921.
26. Antiepileptic drugs, 4th edition (Eds R. Levy, R.H. Mattson and B.S. Meldrum). New York, Raven Press, 1995.
27. Wyllie E. (Course Director) American Epilepsy Society Annual Course. New developments in antiepileptic drug therapy. Epilepsia 1995; 36(Suppl. 2).